Random-effects model for meta-analysis of clinical trials: An update

Contemporary Clinical Trials

Volumn 28, Issue 2, 2007, Pages 105-114

  DerSimonian, Rebecca ^a   Kacker, Raghu ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Clinical trials; Meta analysis; Random effects model; Restricted maximum likelihood; Variance components

Indexed keywords

ARTICLE; COMPUTER PROGRAM; META ANALYSIS; RANDOMIZATION; STATISTICAL PARAMETERS; THEORETICAL MODEL; TREATMENT OUTCOME; VARIANCE;

ALGORITHMS; ANALYSIS OF VARIANCE; CLINICAL TRIALS; COMPUTER SIMULATION; HUMANS; META-ANALYSIS; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 33845571913     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.04.004     Document Type: Article

References (18)

1. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-187
2. DerSimonian R., and Levine R. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. JAMA 282 (1999) 664-670
3. Paule R.C., and Mandel J. Consensus values and weighting factors. J Res Natl Bur Stand 87 (1982) 377-385
4. Rukhin A.L., Biggerstaff B.J., and Vangel M.G. Restricted maximum likelihood estimation of common mean and the Mandel-Paule algorithm. J Stat Plan Inference 83 (2000) 319-330
5. Cochran W.G. The combination of estimates from different experiments. Biometrics 10 (1954) 101-129
6. Kackar R.N., and Harville D.A. Approximations for standard errors of estimators of fixed and random effects in mixed linear models. J Am Stat Assoc 79 (1984) 853-862
7. Bohning D., Malzahn U., Dietz E., et al. Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics 3 4 (2002) 445-457
8. Kacker R.N. Combining information from interlaboratory evaluations using a random effects model. Metrologia 41 (2004) 132-136
9. Harville D.A. Maximum likelihood approaches to variance component estimation and to related problems. J Am Stat Assoc 72 (1977) 320-340
10. Baum M.L., Anish D.S., Chalmers T.C., et al. A survey of clinical trials of antibiotics prophylaxis in colon surgery: evidence against further use of no-treatment controls. NEJM 305 (1981) 795-799
11. Teo K., Yusuf S., Collins R., Held P., and Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ 303 (1991) 1499-1503
12. CLASP. A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 (1994) 619-629
13. Anand S.S., and Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA 282 (1999) 2058-2067
14. Bradley D.J., Bradley E.A., Baugham K.L., et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 289 (2003) 730-740
15. Llovet J., and Bruix J for the Barcelona-Clinic Liver Cancer Group. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
16. Yusuf S., Peto R., Lewis J., Collins R., and Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
17. Gilbert J.P., McPeek B., and Mosteller F. Progress in surgery and anesthesia: benefits and risks of innovative therapy. In: Bunker J.P., Barnes B.A., and Mosteller F. (Eds). Costs, risks and benefit of surgery (1977), Oxford University Press, New York 124-169
18. Whitehead A. Meta-analysis of controlled clinical trials (2003), Wiley, New York